IMMUNOCORE HOLDINGS PLC-ADR
IMCR · NASDAQ
Updated at 2026-10-13 14:35:20
- Today's High
- $29.26
- Today’s Low
- $28.33
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $29.48
- Previous Close
- $29.04
- Volume
- 219.72K
- Market Cap
- $1.51B
- P/E Ratio
- --
- EPS
- $-0.36
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 92 PARK DRIVE, ABINGDON, UNITED KINGDOM, OX14 4RY
- Country
- GB
- Listing Date
- 2021-02-05
- Fiscal Year End
- December
- Shares Outstanding
- 50.87M
- CIK
- 0001671927
- Website
- www.immunocore.com
Immunocore Holdings Limited, an advanced stage biotechnology company, develops immunotherapies for the treatment of cancer, infectious and autoimmune diseases. The company is headquartered in Abingdon, the United Kingdom.
Financial Metrics
Revenue
2026-06-30
$115.92M
2026-03-31
$106.67M
2025-12-31
$77.42M
2025-09-30
$103.69M
Operating Expenses
2026-06-30
$117.83M
2026-03-31
$98.96M
2025-12-31
$89.39M
2025-09-30
$110.35M
Net Income
2026-06-30
-$808K
2026-03-31
$12.97M
2025-12-31
-$22.27M
2025-09-30
$785K
Net Profit Margin
2026-06-30
-0.69%
2026-03-31
12.15%
2025-12-31
-28.77%
2025-09-30
0.75%
Earnings Per Share
2026-06-30
$-0.02
2026-03-31
$0.25
2025-12-31
$-0.60
2025-09-30
$0.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$3.57M
2026-03-31
$16.52M
2025-12-31
-$7.81M
2025-09-30
$4.14M
Effective Tax Rate
2026-06-30
-57.19%
2026-03-31
2.26%
2025-12-31
-90.32%
2025-09-30
-158.22%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $115.92M | $106.67M | $77.42M | $103.69M |
| Operating Expenses | $117.83M | $98.96M | $89.39M | $110.35M |
| Net Income | -$808K | $12.97M | -$22.27M | $785K |
| Net Profit Margin | -0.69% | 12.15% | -28.77% | 0.75% |
| Earnings Per Share | $-0.02 | $0.25 | $-0.60 | $0.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $3.57M | $16.52M | -$7.81M | $4.14M |
| Effective Tax Rate | -57.19% | 2.26% | -90.32% | -158.22% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.